[Featured Stock] JinMatrix Hits Record High on News of European Certification for COVID-19 Diagnostic Kit View original image

[Asia Economy Reporter Eunmo Koo] Jin Matrix is showing strong performance, recording a new high for two consecutive days. The news of the novel coronavirus (COVID-19) diagnostic kit 'Neoplex COVID-19' obtaining European in vitro diagnostic reagent (CE-IVD) certification appears to be influencing this trend.


As of 9:28 AM on the 11th, Jin Matrix was trading at 5,040 KRW, up 4.56% (220 KRW) from the previous trading day. During the session, the price rose to 5,820 KRW, marking a 52-week high.



Jin Matrix announced the day before that its recently developed COVID-19 diagnostic kit, 'Neoplex COVID-19,' had obtained European CE-IVD certification. Neoplex COVID-19 ensures efficiency and simplicity for large-scale testing and significantly reduces the diagnostic time from the previous 6 hours to 3 hours.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing